Health Catalyst (HCAT) Tops Q3 EPS by 4c

Health Catalyst (NASDAQ: HCAT) reported Q3 EPS of ($0.18), $0.04 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $61.74 million versus the consensus estimate of $60.81 million.

GUIDANCE:

Health Catalyst sees FY2021 revenue of $238.6-241.6 million, versus the consensus of $239 million.

For earnings history and earnings-related data on Health Catalyst (HCAT) click here.

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• Mammoth Energy Services (TUSK) Reports Q2 Loss of $0.01
• Revelation Biosciences (REVB) Misses Q2 EPS by 4c